首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

1489160

全球大麻藥品市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Cannabis Pharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 121 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球大麻藥品市場需求預計將從 2023 年的 39.7 億美元達到近 1,916.8 億美元的市場規模，2024-2032 年研究期間複合年成長率為 53.86%。

大麻藥品是從大麻植物中提取的醫療產品，旨在治療各種健康狀況。這些藥物含有大麻素（例如 THC 和 CBD）等活性化合物，並且有多種形式，包括油劑、膠囊、噴霧劑和局部應用。它們用於治療慢性疼痛、癲癇、多發性硬化症和化療引起的噁心等症狀。這些都是根據嚴格的監管標準開發的，以確保一致性、安全性和有效性。隨著研究不斷驗證其治療功效以及合法化在許多地區的擴大，它們的使用正在不斷成長。

市場動態

各國對醫用大麻的日益接受和合法化主要是在市場成長期間。隨著越來越多的地區認知到大麻的治療功效，對醫藥級大麻產品的需求不斷增加。此外，越來越多的研究和臨床試驗證明大麻在解決癲癇、慢性疼痛和多發性硬化症等多種醫療狀況方面的功效，正在推動市場成長。標準化大麻配方和劑量的開發確保了一致性和安全性，使這些產品對醫療保健提供者和患者更具吸引力。此外，人口老化更容易出現可以用大麻藥物治療的疾病，這極大地促進了市場需求。

萃取和配方技術的進步也推動了市場的發展，使高品質、純淨和有效的大麻藥品的生產成為可能。製藥公司對基於大麻的新療法的研究和開發的投資不斷增加，預計將產生創新產品並擴大現有藥物的適應症。此外，醫學界和患者對大麻藥物益處的認知和接受程度不斷提高，進一步推動了市場成長。然而，嚴格的法規和社會恥辱可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對大麻製藥全球市場的每個細分市場進行了包容性評估。大麻製藥業的成長和趨勢為本研究提供了整體方法。

市場區隔

大麻製藥市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按類型

薩蒂克斯
Epidiolex
其他品牌

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲大麻製藥市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。大麻製藥市場的主要參與者包括 Jazz Pharmaceuticals Inc.、AbbVie Inc.、Insys Therapeutics Inc.、Bausch Health Companies Inc.。夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 7 章：大麻製藥公司的競爭格局

大麻藥品市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 8 章：公司簡介

頂級公司市佔率分析
市場集中度
Jazz Pharmaceuticals Inc.

公司簡介
公司收入
產品
最近的發展

AbbVie Inc.

公司簡介
公司收入
產品
最近的發展

Insys Therapeutics Inc.

公司簡介
公司收入
產品
最近的發展

Bausch Health Companies Inc

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114737

The global demand for Cannabis Pharmaceuticals Market is presumed to reach the market size of nearly USD 191.68 Billion by 2032 from USD 3.97 Billion in 2023 with a CAGR of 53.86% under the study period 2024-2032.

Cannabis pharmaceuticals are medical products derived from the cannabis plant, formulated to treat various health conditions. These pharmaceuticals contain active compounds such as cannabinoids (e.g., THC and CBD) and are available in multiple forms, including oils, capsules, sprays, and topical applications. They are used to manage symptoms of chronic pain, epilepsy, multiple sclerosis, and chemotherapy-induced nausea, among others. These are developed under strict regulatory standards to ensure consistency, safety, and efficacy. Their use is growing as research continues to validate their therapeutic benefits and as legalization expands in many regions.

MARKET DYNAMICS

The growing acceptance & legalization of cannabis for medical use in various countries is primarily during market growth. As more regions recognize the therapeutic benefits of cannabis, the demand for pharmaceutical-grade cannabis products rises. Additionally, growing research and clinical trials demonstrating the efficacy of cannabis in addressing an extensive range of medical conditions, such as epilepsy, chronic pain, and multiple sclerosis, are boosting market growth. The development of standardized cannabis formulations and dosages ensures consistency and safety, making these products more appealing to both healthcare providers and patients. Furthermore, the aging population, which is more prone to conditions that can be treated with cannabis pharmaceuticals, significantly contributes to market demand.

Advances in extraction and formulation technologies are also driving the market, enabling the production of high-quality, pure, and effective cannabis pharmaceuticals. The increasing investment by pharmaceutical companies in the research and development of new cannabis-based therapies is expected to result in innovative products and expanded indications for existing medications. Additionally, growing awareness and acceptance among the medical community and patients regarding the benefits of cannabis pharmaceuticals further drive market growth. However, stringent regulations and societal stigma may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cannabis Pharmaceuticals. The growth and trends of Cannabis Pharmaceuticals industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cannabis Pharmaceuticals market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Sativex
Epidiolex
Other Brands

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cannabis Pharmaceuticals market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cannabis Pharmaceuticals market include Jazz Pharmaceuticals Inc., AbbVie Inc., Insys Therapeutics Inc., Bausch Health Companies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CANNABIS PHARMACEUTICALS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANNABIS PHARMACEUTICALS MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Sativex Historic and Forecast Sales By Regions
5.4. Epidiolex Historic and Forecast Sales By Regions
5.5. Other Brands Historic and Forecast Sales By Regions

6. GLOBAL CANNABIS PHARMACEUTICALS MARKET ANALYSIS BY GEOGRAPHY

6.1. Regional Outlook
6.2. Introduction
6.3. North America Sales Analysis
- 6.3.1 Overview, Historic and Forecast Data Sales Analysis
- 6.3.2 North America By Segment Sales Analysis
- 6.3.3 North America By Country Sales Analysis
- 6.3.4 United States Sales Analysis
- 6.3.5 Canada Sales Analysis
- 6.3.6 Mexico Sales Analysis
6.4. Europe Sales Analysis
- 6.4.1 Overview, Historic and Forecast Data Sales Analysis
- 6.4.2 Europe By Segment Sales Analysis
- 6.4.3 Europe By Country Sales Analysis
- 6.4.4 United Kingdom Sales Analysis
- 6.4.5 France Sales Analysis
- 6.4.6 Germany Sales Analysis
- 6.4.7 Italy Sales Analysis
- 6.4.8 Russia Sales Analysis
- 6.4.9 Rest Of Europe Sales Analysis
6.5. Asia Pacific Sales Analysis
- 6.5.1 Overview, Historic and Forecast Data Sales Analysis
- 6.5.2 Asia Pacific By Segment Sales Analysis
- 6.5.3 Asia Pacific By Country Sales Analysis
- 6.5.4 China Sales Analysis
- 6.5.5 India Sales Analysis
- 6.5.6 Japan Sales Analysis
- 6.5.7 South Korea Sales Analysis
- 6.5.8 Australia Sales Analysis
- 6.5.9 South East Asia Sales Analysis
- 6.5.10 Rest Of Asia Pacific Sales Analysis
6.6. Latin America Sales Analysis
- 6.6.1 Overview, Historic and Forecast Data Sales Analysis
- 6.6.2 Latin America By Segment Sales Analysis
- 6.6.3 Latin America By Country Sales Analysis
- 6.6.4 Brazil Sales Analysis
- 6.6.5 Argentina Sales Analysis
- 6.6.6 Peru Sales Analysis
- 6.6.7 Chile Sales Analysis
- 6.6.8 Rest of Latin America Sales Analysis
6.7. Middle East & Africa Sales Analysis
- 6.7.1 Overview, Historic and Forecast Data Sales Analysis
- 6.7.2 Middle East & Africa By Segment Sales Analysis
- 6.7.3 Middle East & Africa By Country Sales Analysis
- 6.7.4 Saudi Arabia Sales Analysis
- 6.7.5 UAE Sales Analysis
- 6.7.6 Israel Sales Analysis
- 6.7.7 South Africa Sales Analysis
- 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE CANNABIS PHARMACEUTICALS COMPANIES

7.1. Cannabis Pharmaceuticals Market Competition
7.2. Partnership/Collaboration/Agreement
7.3. Merger And Acquisitions
7.4. New Product Launch
7.5. Other Developments

8. COMPANY PROFILES OF CANNABIS PHARMACEUTICALS INDUSTRY

8.1. Top Companies Market Share Analysis
8.2. Market Concentration Rate
8.3. Jazz Pharmaceuticals Inc.
- 8.3.1 Company Overview
- 8.3.2 Company Revenue
- 8.3.3 Products
- 8.3.4 Recent Developments
8.4. AbbVie Inc.
- 8.4.1 Company Overview
- 8.4.2 Company Revenue
- 8.4.3 Products
- 8.4.4 Recent Developments
8.5. Insys Therapeutics Inc.
- 8.5.1 Company Overview
- 8.5.2 Company Revenue
- 8.5.3 Products
- 8.5.4 Recent Developments
8.6. Bausch Health Companies Inc
- 8.6.1 Company Overview
- 8.6.2 Company Revenue
- 8.6.3 Products
- 8.6.4 Recent Developments